Breakpoints

113 Episodo

1. #73 – You’re a Breakpoint, Harry: Magical Insights from CLSI and USCAST

   Publicado: 24/3/2023
2. #72 – This Isn't Just a Phage: A Discussion on Bacteriophage Therapy

   Publicado: 17/3/2023
3. #71 – This is a Potential Breakup Song: Controversies in the Management of Infective Endocarditis

   Publicado: 17/2/2023
4. #70 – Stewardship Struggles

   Publicado: 20/1/2023
5. #69 – IDWeek 2022 Recap: Practice Changing Publications – Midnights Edition

   Publicado: 30/12/2022
6. #68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

   Publicado: 23/12/2022
7. #67 – Nixing the Nidus: Managing Retained Sources in Prosthetic Joint Infections

   Publicado: 25/11/2022
8. #66 – The Swinging PEN-dulum: Evolving Approaches to Cephalosporin Use in Penicillin Allergic Patients

   Publicado: 18/11/2022
9. #65 – Into the Unknown: Exploring Fever of Unknown Origin with Febrile Podcast

   Publicado: 14/10/2022
10. #64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals

    Publicado: 23/9/2022
11. #63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults

    Publicado: 16/9/2022
12. #62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs

    Publicado: 26/8/2022
13. #61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring

    Publicado: 19/8/2022
14. #60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

    Publicado: 22/7/2022
15. #59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils

    Publicado: 15/7/2022
16. #58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines

    Publicado: 24/6/2022
17. #57 – Dosing Consult: Ceftriaxone

    Publicado: 27/5/2022
18. #56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives

    Publicado: 15/4/2022
19. #55 – One World: Global Perspectives in Antimicrobial Stewardship

    Publicado: 25/3/2022
20. #54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies

    Publicado: 18/3/2022